Dr. Kaiserman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1401 W Merced Ave
Ste 101
West Covina, CA 91790Phone+1 626-813-9988Fax+1 626-813-0075
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Endocrinology, 1995 - 1998
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1992 - 1995
- Eastern Virginia Medical SchoolClass of 1992
Certifications & Licensure
- CA State Medical License 1994 - 2026
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
- Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Start of enrollment: 2016 Apr 18
- Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System Start of enrollment: 2019 Jul 24
Publications & Presentations
PubMed
- 19 citationsAccuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes.Robert H. Slover, Jeanie B. Tryggestad, Linda A. DiMeglio, Larry A. Fox, Bruce W. Bode
Diabetes Technology & Therapeutics. 2018-09-01 - 29 citationsMinipuberty of infancy and adolescent pubertal function in adrenal hypoplasia congenitaKevin B. Kaiserman, Jon M. Nakamoto, Mitchell E. Geffner, Edward R.B. McCabe
The Journal of Pediatrics. 1998-08-01 - 34 citationsGlycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.Gregory P Forlenza, Laya Ekhlaspour, Linda A DiMeglio, Larry A Fox, Henry Rodriguez
Pediatric Diabetes. 2022-05-01
Press Mentions
- MannKind Presents Data at 21st Annual Diabetes Technology MeetingNovember 5th, 2021
- MannKind Announces Data Presentation at 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021) to Be Held Virtually June 2-5June 3rd, 2021
- Medtronic Wins FDA’s Breakthrough Status for Closed-Loop Insulin SystemFebruary 19th, 2019
- Join now to see all
Grant Support
- DAX1 Function In Adrenocortical DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: